The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized trial of fixed dose capecitabine compared to standard dose capecitabine in metastatic breast cancer: The X-7/7 trial.
 
Qamar J. Khan
No Relationships to Disclose
 
Colleen Bohnenkamp
No Relationships to Disclose
 
Taylor Monson
No Relationships to Disclose
 
Holly E Smith
No Relationships to Disclose
 
Milind A. Phadnis
No Relationships to Disclose
 
Vinay Raja
No Relationships to Disclose
 
Manana Elia
No Relationships to Disclose
 
Anne O'Dea
Honoraria - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer; Puma Biotechnology
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer; Puma Biotechnology; Seagen; Stemline Therapeutics
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer; Puma Biotechnology
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Pfizer; Puma Biotechnology
 
Gregory James Crane
No Relationships to Disclose
 
Mark Robert Fesen
No Relationships to Disclose
 
Lauren Elizabeth Nye
Consulting or Advisory Role - bioTheranostics; Myriad Genetic Laboratories
Travel, Accommodations, Expenses - Ambry Genetics
 
Maureen Sheehan
No Relationships to Disclose
 
Robert E. Pluenneke
No Relationships to Disclose
 
Raed Moh'd Taiseer Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - AstraZeneca; Bayer
Speakers' Bureau - Sirtex Medical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lexicon (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Joaquina Celebre Baranda
Stock and Other Ownership Interests - Aprea Therapeutics; Forty Seven; Hylapharm; Merus NV; Moderna Therapeutics; MorphoSys; Zymeworks
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Incyte (Inst); Lilly (Inst); Nektar (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tolero Pharmaceuticals (Inst); Xencor (Inst)
 
Anup Kasi
Consulting or Advisory Role - Ipsen
Research Funding - Ability Pharma (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
 
Richard J. McKittrick
Employment - Oak Street Health (I)
 
Laura Mitchell
No Relationships to Disclose
 
Stephanie LaFaver
No Relationships to Disclose
 
Priyanka Sharma
Stock and Other Ownership Interests - Amgen Astellas BioPharma (I)
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; GlaxoSmithKline; Merck; Novartis; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences; Merck (Inst); Novartis; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate